09:56 AM EST - WELL Health Technologies Corp. : Announced its interim consolidated financial results for the quarter ended September 30, 2024. WELL surpassed $1 billion annualized revenue run-rate with record revenue of $251.7 million in Q3-2024, marking a 27% increase compared to Q3-2023, mainly driven by organic growth of 23%. WELL achieved record Adjusted EBITDA of $32.7 million in Q3-2024, an increase of 16% as compared to Q3-2023.
WELL Health Technologies Corp.
shares T.WELL are trading up $0.22 at $4.74.
